Professional Documents
Culture Documents
Lung Cancer Kuliah
Lung Cancer Kuliah
Erlina Marfianti
IPD FK UII
Etiology
Radiation Exposure
Smoking
Environmental/ Occupational
Exposure
Asbestos
Radon
Passive smoke
Smoking Facts
Tobacco use is the
leading cause of lung
cancer
87% of lung cancers
are related to smoking
Risk related to:
Metastase
Lymph Nodes, Brain, Liver, Adrenal,
Gland, Bones
40% of metastasis occurs in the
Adrenal Gland
Screening
No approved screening test proven to improve survival
or detect localized disease
Clinical studies are under way
Diagnosis
Physical exam
Chest X-ray
CT Scan
PET Scan
MRI
Sputum sample
Bronchoscopy
Biopsy
PET Scan
CT Scan
Chest Xray
Symptoms
Syndromes/Symptoms secondary
to regional metastases:
Esophageal compression dysphagia
Laryngeal nerve paralysis hoarseness
Symptomatic nerve paralysis Horners
syndrome
Cervical/thoracic nerve invasion Pancoast
syndrome
Lymphatic obstruction pleural effusion
Vascular obstruction SVC syndrome
Pericardial/cardiac extension effusion,
tamponade
Adenocarcinoma
Oat Cell
Intermediate
Combined
Description
Treatment Options
Stage I a/b
Surgery
Stage II a/b
Surgery
Stage III a
Chemotherapy followed
by radiation or surgery
Stage III b
Combination of
chemotherapy and
radiation
Stage IV
Chemotherapy and/or
palliative (maintenance)
care
SCLC
Limited Stage
Defined as tumor involvement of one lung, the
mediastinum and ipsilateral and/or contralateral
supraclavicular lymph nodes or disease that can
be encompassed in a single radiotherapy port.
Extensive Stage
Defined as tumor that has spread beyond one
lung, mediastinum, and supraclavicular lymph
nodes. Common distant sites of metastases are
the adrenals, bone, liver, bone marrow, and brain.
Conclusion
Smoking cessation is essential for
prevention of lung cancer.
New screening tools under way.
Clinical trials under way.
New treatments under way.
Treatment can palliate symptoms and
improve quality of life.
Read first bullet again!!